TSO3 Announces full exercise of underwriters' option to purchase additional units

Ticker:  TSX – TOS
Shares Outstanding: 73,399,656

Not for distribution to U.S. news wire services or dissemination in the United States.

QUÉBEC CITY, March 2, 2015 /CNW Telbec/ - TSO₃ Inc. ("TSO₃" or the "Company") (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, today announced that, in relation to the placement of units on a bought deal basis (the "Offering") announced earlier, the underwriters have exercised their option (the "Underwriters' Option") to purchase an additional 1,200,000 units at a price of C$1.25 per unit. TSO₃ will receive additional gross proceeds of C$1,500,000 from the exercise of the Underwriters' Option, increasing the total size of the offering to C$11,500,000. Closing of the Underwriters' Option is expected to occur concurrent with the closing of the Offering on or about March 5, 2015.

About TSO₃

Founded in 1998, TSO₃'s activities encompass research, development, commercialization and licensing of sterilization processes for heat-sensitive medical devices, related equipment, accessories and consumable supplies. TSO₃ designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals.

For more information about TSO₃, visit the Company's Web site at www.tso3.com.

The statements in this release and oral statements made by representatives of TSO₃ relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO₃) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO₃ to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

SOURCE TSO3 Inc.